VIM
TEVA icon

Vinva Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Vinva Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-187,064
Closed -$4.18M – 435
2024
Q4 		$4.18M Sell
187,064
-30,656
-14% -$558K 0.16% 147
2024
Q3 		$3.8M Buy
217,720
+197,270
+965% +$3.45M 0.16% 146
2024
Q2 		$333K Sell
20,450
-13,553
-40% -$209K 0.02% 385
2024
Q1 		$480K Buy
34,003
+3,037
+10% +$38.3K 0.03% 375
2023
Q4 		$324K Buy
30,966
+13,144
+74% +$123K 0.02% 364
2023
Q3 		$182K Buy
+17,822
New +$166K 0.02% 353

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Vinva Investment Management's TEVA Position: Q1 2025 in Review

Vinva Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2025, closing a stake of 187,064 shares — an estimated $4.18M sold.

Vinva Investment Management first reported a position in TEVA in Q3 2023 and held it in 6 quarters. The position peaked at $4.18M in Q4 2024. 560 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • Vinva Investment Management reported no remaining Teva Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Vinva Investment Management sold 187,064 Teva Pharmaceuticals shares in Q1 2025, an estimated $4.18M.
  • Vinva Investment Management first reported a position in Teva Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • Vinva Investment Management's Teva Pharmaceuticals position peaked at $4.18M in Q4 2024.
  • 560 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2025.

Based on Vinva Investment Management's 13F filing for Q1 2025, filed 14 May 2025.